Latest Financials News

Tinybeans Group announces a leadership reshuffle with Tracy Cho as Interim CEO and Rebecca White joining the Board, sharpening its focus on expanding in the lucrative U.S. family market.

Mayne Pharma has announced a planned leadership transition with CFO Aaron Gray stepping up as CEO, succeeding Shawn Patrick O’Brien who will remain as an advisor during the handover.

Navigator Global Investments reported a 17% rise in adjusted EBITDA to USD48.2 million for H1 FY26, driven by strong performance fees and asset growth, though full-year earnings face headwinds.

Medallion Metals Limited has extended the deadline for its acquisition of the Forrestania Nickel Operation from IGO Limited, with completion expected by 27 February 2026. The transaction remains on track despite a few outstanding conditions.

Pantoro Gold has announced a significant on-market share buy-back of up to 10% of its shares, leveraging strong cashflow from its Norseman Gold Project to enhance shareholder value while funding growth.

VEEM Limited reports half-year revenue close to guidance with improved cash flow, offset by a significant $24.8 million non-cash impairment tied to its gyro product upgrade. The transition to the new Mark III gyro design has temporarily stalled sales as customers await delivery.

Solstice Minerals has reported robust copper-gold assay results from its Phase 1 drilling at the Nanadie Project in Western Australia, revealing significant mineralisation beyond the current resource boundaries. These findings reinforce the project's potential for substantial resource growth and underpin plans for further drilling.

Sunshine Metals has reported outstanding high-grade gold and silver intercepts from its recent drilling at the Liontown deposit, reinforcing the project's significant precious metals potential and setting the stage for an updated resource and mining study.

Barton Gold Holdings has distributed over $640,000 in Junior Minerals Exploration Incentive tax credits to investors from its June 2025 placement, enhancing returns amid strong exploration activity.

EMVision Medical Devices reported a $3.97 million loss for H1 2026, up 11% year-on-year, driven by increased share-based payments and expanded clinical activities. The company secured a $3 million government grant to advance stroke diagnosis in regional Australia.

Tivan Limited has submitted a confidential draft Feasibility Study for its Speewah Fluorite Project to key partners, marking a significant step towards project finalisation and potential production.

Symal Group Limited reported a robust half-year performance with revenues climbing 24.6% to $504.2 million and announced key acquisitions to bolster its infrastructure footprint. The company also secured $300 million in new debt facilities to support its expansion plans.